Veronique Fremeaux-Bacchi Selected Research

Atypical Hemolytic Uremic Syndrome

1/2019	Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology.
12/2017	C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
10/2017	A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
11/2016	Endothelial cells: source, barrier, and target of defensive mediators.
4/2016	Defining the genetics of thrombotic microangiopathies.
4/2015	Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.
9/2014	Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?
6/2014	Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
12/2013	Complement factor H related proteins (CFHRs).
7/2013	Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veronique Fremeaux-Bacchi Research Topics

Disease

25	Atypical Hemolytic Uremic Syndrome 01/2019 - 01/2007
7	Glomerulonephritis 01/2019 - 01/2008
5	Hemolysis 01/2020 - 01/2008
5	Chronic Kidney Failure (Chronic Renal Failure) 03/2016 - 02/2007
4	Inflammation (Inflammations) 01/2019 - 06/2014
4	Infections 01/2019 - 02/2009
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 03/2011
4	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 11/2017 - 02/2009
4	Thrombotic Microangiopathies 09/2015 - 05/2012
3	Lupus Nephritis 01/2019 - 10/2015
3	Autoimmune Diseases (Autoimmune Disease) 07/2015 - 03/2011
3	Macular Degeneration (Age-Related Maculopathy) 01/2015 - 12/2005
2	Neoplasms (Cancer) 01/2021 - 01/2015
2	Thrombosis (Thrombus) 01/2019 - 07/2013
2	Thrombotic Thrombocytopenic Purpura 11/2016 - 04/2016
2	IGA Glomerulonephritis (IGA Nephropathy) 07/2015 - 12/2013
2	Renal Insufficiency (Renal Failure) 07/2014 - 11/2013
2	Spontaneous Abortion (Miscarriage) 06/2013 - 03/2011
2	Hypertension (High Blood Pressure) 08/2009 - 02/2009
2	Hemolytic-Uremic Syndrome 01/2008 - 02/2007
1	Edema (Dropsy) 04/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Rhabdomyolysis 01/2021
1	COVID-19 12/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Necrosis 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Kidney Diseases (Kidney Disease) 12/2017
1	Hereditary Complement Deficiency Diseases 01/2015
1	Vasculitis (Vasculitides) 06/2014
1	Vascular System Injuries 11/2013
1	Habitual Abortion (Recurrent Miscarriage) 06/2013
1	Streptococcal Infections (Streptococcal Infection) 07/2012
1	Pre-Eclampsia (Preeclampsia) 03/2011
1	Protein Deficiency 02/2011
1	Myocardial Infarction 06/2010
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2010
1	Proteinuria 02/2009
1	Choroidal Neovascularization 07/2008
1	Angiomatosis 07/2008
1	HELLP Syndrome 01/2008
1	Uniparental Disomy 02/2007

Drug/Important Bio-Agent (IBA)

36	Complement System Proteins (Complement)IBA 01/2021 - 02/2007
9	Complement Factor H (Factor H)IBA 01/2020 - 12/2005
6	Proteins (Proteins, Gene)FDA Link 10/2017 - 02/2009
6	Fibrinogen (Factor I)FDA Link 02/2010 - 02/2007
6	Membrane Cofactor ProteinIBA 02/2010 - 01/2007
5	Heme (Haem)IBA 01/2021 - 07/2013
3	Complement C3 (C3 Complement)IBA 01/2021 - 08/2009
3	EnzymesIBA 01/2021 - 01/2008
3	AutoantibodiesIBA 01/2019 - 02/2009
3	AntibodiesIBA 01/2019 - 07/2015
3	Alternative Pathway Complement C3 ConvertaseIBA 11/2017 - 02/2009
3	chemotactic factor inactivatorIBA 02/2013 - 01/2008
3	Complement Factor I (C3b Inactivator)IBA 03/2011 - 01/2008
2	Complement C5 (Complement 5)IBA 04/2021 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 07/2015
2	eculizumab FDA Link 09/2015 - 06/2014
2	Dichlorodiphenyldichloroethane (DDD)IBA 12/2013 - 02/2009
2	Complement Inactivating AgentsIBA 06/2013 - 02/2010
2	Complement C3-C5 Convertases (C3 Convertase)IBA 02/2012 - 09/2009
1	Complement C1s (C1 Esterase)IBA 01/2021
1	HemopexinIBA 01/2021
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Immunoglobulin G (IgG)IBA 01/2019
1	CytokinesIBA 01/2019
1	EpitopesIBA 01/2019
1	Heme Oxygenase-1IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	CoagulantsIBA 01/2018
1	ADAMTS13 ProteinIBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	lead sulfide (kohl)IBA 09/2015
1	galactosyl-deficient IgA1IBA 07/2015
1	LectinsIBA 07/2015
1	Complement Factor B (Factor B)IBA 09/2014
1	Complement C4b-Binding ProteinIBA 06/2013
1	Antiphospholipid AntibodiesIBA 03/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2011
1	Complement C3 Nephritic FactorIBA 02/2009
1	Retinaldehyde (Retinal)IBA 07/2008
1	NucleotidesIBA 02/2007

Therapy/Procedure

3	Therapeutics 07/2015 - 06/2014
2	Kidney Transplantation 11/2013 - 02/2009
1	Drug Therapy (Chemotherapy) 01/2020
1	Hematopoietic Stem Cell Transplantation 09/2015
1	Transplantation 06/2014
1	Resuscitation 06/2010